• Profile
Close

The novel lncRNA p4516 acts as a prognostic biomarker promoting gastric cancer cell proliferation and metastasis

Cancer Management and Research Jun 19, 2019

Nie ML, et al. - Researchers investigated the exact biological functions as well as the underlying molecular mechanisms of p4516 [a novel long noncoding RNA (lncRNA)] in gastric tumorigenesis. In both gastric cancer (GC) cell lines and in 142 primary GC tissues, they evaluated p4516 expression levels using qRT-PCR. The main location of lncRNA p4516 was the nucleus of GC cells. GC cells vs normal gastric mucosa-derived cells GES-1 exhibited higher expression levels of p4516. In GC patients, a correlation of higher expression levels of p4516 with worse clinical outcomes was observed. Both in vivo and in vitro, the participation of p4516 in the regulation of GC cell proliferation, invasion and migration was found in functional analysis. p4516 was implicated in epithelial–mesenchymal transition in GC cells. For the first time, novel lncRNA p4516 was shown to have an oncogenic role in the gastric carcinogenesis. In GC patients, high expression of p4516 may serve as prognostic marker.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay